TXR1-mediated thrombospondin repression: a novel mechanism of resistance to taxanes?
van Amerongen
Renée
R
Netherlands Cancer Institute, Division of Molecular Genetics and Centre of Biomedical Genetics, Amsterdam.
Berns
Anton
A
D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D001952:Bridged-Ring Compounds / Q000494:pharmacology*; D019008:Drug Resistance, Neoplasm; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D012097:Repressor Proteins / Q000502:physiology*; D043823:Taxoids / Q000494:pharmacology*; D019700:Thrombospondin 1 / Q000235:genetics / Q000378:metabolism*
D000970:Antineoplastic Agents; D001952:Bridged-Ring Compounds; C513606:PRR13 protein, human; D012097:Repressor Proteins; D043823:Taxoids; D019700:Thrombospondin 1; C080625:taxane